Literature DB >> 16263609

Immune response and effect of adenovirus-mediated human BMP-2 gene transfer on the repair of segmental tibial bone defects in goats.

X Leon Xu1, Tingting Tang, Kerong Dai, Zhen'an Zhu, X Edward Guo, Chaofeng Yu, Jueren Lou.   

Abstract

BACKGROUND: Tissue-engineered bone may be used for filling bone defects. There are, however, no reports on this technique used in large animals.
METHODS: We evaluated the effectiveness of, and immune response in repairing diaphyseal bone defects by gene transfer using bone morphogenetic proteins (BMPs). We used adenovirus-mediated human BMP-2 (Adv-hBMP-2) gene-transduced bone marrow stromal cells (BMSCs) to repair 2.1-cm segmental tibial bone defects in goats (group I, n = 7). An Adv-ssgal-transduced BMSC group (group II, n = 5), a non-transduced BMSC group (group III, n = 5), and an untreated group (group IV, n = 2) were used as controls. Self-secreted extracellular matrix was used as cellular carrier.
RESULTS: Radiographic and histomorphometric examination demonstrated more callus in the bone defects of group I compared to other groups. Week 24 after implantation, the defect healing rates of groups I, II, III, and IV were 6/7, 1/5, 2/5, and 0/2, respectively. The maximum compressive strength of new tissue in the bone defects of group I was higher than those of groups II and III. Temporary cellular and persistent humoral immune responses against adenovirus were detected after hBMP-2 gene transfer.
INTERPRETATION: We found that Adv-hBMP-2 genetransduced BMSCs had superior osteoinductivity in the repair of tibial bone defects in goats, but it could cause temporary cellular and persistent humoral immune responses against adenovirus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263609     DOI: 10.1080/17453670510041709

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


  17 in total

Review 1.  Gene therapy for the regeneration of bone.

Authors:  Christopher Evans
Journal:  Injury       Date:  2011-04-13       Impact factor: 2.586

2.  Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2.

Authors:  Tien-Min G Chu; Stuart J Warden; Charles H Turner; Rena L Stewart
Journal:  Biomaterials       Date:  2006-09-25       Impact factor: 12.479

Review 3.  Evolving gene therapy approaches for osteosarcoma using viral vectors: review.

Authors:  M A Witlox; M L Lamfers; P I J M Wuisman; D T Curiel; G P Siegal
Journal:  Bone       Date:  2006-12-26       Impact factor: 4.398

4.  LvBMP-2 gene-modified BMSCs combined with calcium phosphate cement scaffolds for the repair of calvarial defects in rats.

Authors:  Chao Zhu; Qing Chang; Duohong Zou; Wenjie Zhang; Shaoyi Wang; Jun Zhao; Wenwen Yu; Xiuli Zhang; Zhiyuan Zhang; Xinquan Jiang
Journal:  J Mater Sci Mater Med       Date:  2011-06-18       Impact factor: 3.896

Review 5.  Gene therapy for bone healing.

Authors:  Christopher H Evans
Journal:  Expert Rev Mol Med       Date:  2010-06-23       Impact factor: 5.600

6.  In situ bone tissue engineering via ultrasound-mediated gene delivery to endogenous progenitor cells in mini-pigs.

Authors:  Maxim Bez; Dmitriy Sheyn; Wafa Tawackoli; Pablo Avalos; Galina Shapiro; Joseph C Giaconi; Xiaoyu Da; Shiran Ben David; Jayne Gavrity; Hani A Awad; Hyun W Bae; Eric J Ley; Thomas J Kremen; Zulma Gazit; Katherine W Ferrara; Gadi Pelled; Dan Gazit
Journal:  Sci Transl Med       Date:  2017-05-17       Impact factor: 17.956

Review 7.  Current status of gene therapy for rheumatoid arthritis.

Authors:  Daniel F Gaddy; Paul D Robbins
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

8.  Repair of goat tibial defects with bone marrow stromal cells and beta-tricalcium phosphate.

Authors:  Guangpeng Liu; Li Zhao; Wenjie Zhang; Lei Cui; Wei Liu; Yilin Cao
Journal:  J Mater Sci Mater Med       Date:  2007-12-25       Impact factor: 3.896

9.  Evaluation of an injectable, photopolymerizable three-dimensional scaffold based on D: ,L: -lactide and epsilon-caprolactone in a tibial goat model.

Authors:  Geert Vertenten; Lieven Vlaminck; Tomasz Gorski; Elke Schreurs; Wim Van Den Broeck; Luc Duchateau; Etienne Schacht; Frank Gasthuys
Journal:  J Mater Sci Mater Med       Date:  2008-02-29       Impact factor: 3.896

Review 10.  Orthopedic gene therapy in 2008.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.